Frontiers in Cell and Developmental Biology (Mar 2022)

Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model

  • Karen Jansen-West,
  • Tiffany W. Todd,
  • Tiffany W. Todd,
  • Lillian M. Daughrity,
  • Mei Yue,
  • Jimei Tong,
  • Yari Carlomagno,
  • Yari Carlomagno,
  • Giulia Del Rosso,
  • Giulia Del Rosso,
  • Aishe Kurti,
  • Caroline Y. Jones,
  • Judith A. Dunmore,
  • Monica Castanedes-Casey,
  • Dennis W. Dickson,
  • Dennis W. Dickson,
  • Zbigniew K. Wszolek,
  • John D. Fryer,
  • John D. Fryer,
  • Leonard Petrucelli,
  • Leonard Petrucelli,
  • Mercedes Prudencio,
  • Mercedes Prudencio

DOI
https://doi.org/10.3389/fcell.2022.863089
Journal volume & issue
Vol. 10

Abstract

Read online

Spinocerebellar ataxia type 3 (SCA3) is a dominantly inherited cerebellar ataxia caused by the expansion of a polyglutamine (polyQ) repeat in the gene encoding ATXN3. The polyQ expansion induces protein inclusion formation in the neurons of patients and results in neuronal degeneration in the cerebellum and other brain regions. We used adeno-associated virus (AAV) technology to develop a new mouse model of SCA3 that recapitulates several features of the human disease, including locomotor defects, cerebellar-specific neuronal loss, polyQ-expanded ATXN3 inclusions, and TDP-43 pathology. We also found that neurofilament light is elevated in the cerebrospinal fluid (CSF) of the SCA3 animals, and the expanded polyQ-ATXN3 protein can be detected in the plasma. Interestingly, the levels of polyQ-ATXN3 in plasma correlated with measures of cerebellar degeneration and locomotor deficits in 6-month-old SCA3 mice, supporting the hypothesis that this factor could act as a biomarker for SCA3.

Keywords